Key facts
- Notable investors include Jiangsu Jinqiao Private Equity Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Fushenghe Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Fushenghe Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fushenghe Biotechnology
Manufacturer of biotechnology products designed to advance life sciences and healthcare applications. The company operates in the growing biotechnology market with a complete platform for research, development, and production, and its value proposition lies in delivering innovative solutions that support diagnostics, therapeutic development, and scientific innovation for improved healthcare outcomes.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Fushenghe Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fushenghe Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fushenghe Biotechnology in its N-PORT filings yet. We sweep new filings monthly.